Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Deseret News Utah Index
Deseret News Composite
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Silverback Therapeutics Inc
(NQ:
SBTX
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Nov 8, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Silverback Therapeutics Inc
< Previous
1
2
3
4
5
6
Next >
38 Stocks Moving In Thursday's Mid-Day Session
September 16, 2021
Gainers IronNet Cybersecurity, Inc. (NASDAQ: IRNT) shares jumped 30.4% to $41.90 amid increased retail investor interest in the stock on social media. Dutch Bros Inc. (NYSE: BROS...
Via
Benzinga
Mid-Morning Market Update: Markets Down; US Retail Sales Unexpectedly Increase in August
September 16, 2021
Following the market opening Thursday, the Dow traded down 0.45% to 34,657.69 while the NASDAQ fell 0.66% to 15,061.97. The S&P also fell, dropping 0.62% to 4,453.04. The U.S...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Thursday's Pre-Market Session
September 16, 2021
Gainers Leap Therapeutics (NASDAQ:LPTX) stock rose 32.64% to $2.56 during Thursday's pre-market session. The company's market cap stands at $152.7 million. Phio...
Via
Benzinga
The Daily Biotech Pulse: Leap, Phio, Silverback Among Early Movers On Oncology Conference Presentations, Aerie Slumps On Mixed Data, Axsome Commences Phase 3 Sleep Disorder Study
September 16, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 15) Alcon Inc. (NYSE: ALC)...
Via
Benzinga
Silverback Therapeutics Presents Initial Safety Data From Solid Tumor Combo Therapy Trial
September 16, 2021
Silverback Therapeutics Inc (NASDAQ: SBTX) has presented interim data from a Phase 1/1b study of SBT6050 as a monotherapy and in combination with Merck &...
Via
Benzinga
20 Stocks Moving in Thursday's Pre-Market Session
September 16, 2021
Gainers IronNet Cybersecurity, Inc. (NASDAQ: IRNT) rose 59.7% to $51.30 in pre-market trading. IronNet Cybersecurity emerged as the most-discussed stock on Reddit’s r/...
Via
Benzinga
Silverback Therapeutics Presents Interim Clinical Results from the Ongoing Phase 1/1b Study of SBT6050 Alone or In Combination with Pembrolizumab in Patients with Advanced or Metastatic HER2-Expressing Solid Tumors
September 16, 2021
From
Silverback Therapeutics, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's Intraday Session
September 14, 2021
Gainers Progenity (NASDAQ:PROG) shares increased by 17.0% to $1.1 during Tuesday's regular session. As of 12:30 EST, this security is trading at a volume of 40.5...
Via
Benzinga
Why Are Silverback Therapeutics Shares Falling On Monday?
September 13, 2021
Silverback Therapeutics Inc (NASDAQ: SBTX) stock dropped to the lowest level since its IPO in December 2020 in reaction to interim data from SBT6050 Phase 1/1b...
Via
Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
12 Health Care Stocks Moving In Monday's Intraday Session
September 13, 2021
Gainers Itamar Medical (NASDAQ:ITMR) shares increased by 46.58% to $30.25 during Monday's regular session. Trading volume for Itamar Medical's stock is 2.6 million...
Via
Benzinga
The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen's Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout
September 14, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 13) Abbott Laboratories (NYSE...
Via
Benzinga
Exposures
COVID-19
45 Stocks Moving In Monday's Mid-Day Session
September 13, 2021
Gainers Aterian, Inc. (NASDAQ: ATER) jumped 54.1% to $18.18. Investor presentation released on Friday is now circulating on news outlets. Itamar Medical Ltd. (NASDAQ: ITMR)...
Via
Benzinga
72 Biggest Movers From Yesterday
September 14, 2021
Gainers aTyr Pharma, Inc. (NASDAQ: LIFE) jumped 67% to settle at $9.15 on Monday as the company announced positive results from its Phase 1b/2a trial evaluating its lead...
Via
Benzinga
Mid-Morning Market Update: Markets Mixed; UK Terminates Valneva's COVID-19 Vaccine Contract
September 13, 2021
Following the market opening Monday, the Dow traded up 0.61% to 34,817.26 while the NASDAQ fell 0.40% to 15,055.69. The S&P also rose, gaining 0.05% to 4,460.84. The U.S. has...
Via
Benzinga
Topics
Stocks
Exposures
COVID-19
US Equities
12 Health Care Stocks Moving In Monday's Pre-Market Session
September 13, 2021
Gainers Itamar Medical (NASDAQ:ITMR) shares moved upwards by 44.37% to $29.8 during Monday's pre-market session. The market value of their outstanding shares is at $...
Via
Benzinga
Silverback Therapeutics to Present Data from its Phase 1/1b Clinical Trial of SBT6050 at the European Society for Medical Oncology (ESMO) 2021 Virtual Congress
September 13, 2021
From
Silverback Therapeutics, Inc.
Via
Business Wire
Silverback Therapeutics to Participate in the H.C. Wainwright 23rd Annual Global Investment Conference
September 07, 2021
From
Silverback Therapeutics, Inc.
Via
Business Wire
The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization
September 09, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 8) Abbott Laboratories (NYSE:...
Via
Benzinga
Exposures
COVID-19
Silverback Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Update
August 12, 2021
From
Silverback Therapeutics, Inc.
Via
Business Wire
The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab
September 02, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 1) AbbVie Inc. (NASDAQ: ABBV...
Via
Benzinga
Exposures
COVID-19
Product Safety
Silverback Therapeutics to Participate in the 2021 Wedbush PacGrow Healthcare Conference
August 03, 2021
From
Silverback Therapeutics, Inc.
Via
Business Wire
The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical
August 31, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26) Agenus Inc. (NASDAQ: AGEN)...
Via
Benzinga
Silverback Therapeutics Announces Clinical Supply Agreement with Regeneron to Evaluate SBT6050 in Combination with Libtayo® (cemiplimab), initially in HER2-expressing Non-Small Cell Lung and Gastric Cancers
July 07, 2021
From
Silverback Therapeutics, Inc.
Via
Business Wire
Silverback Therapeutics to Participate in the Raymond James Human Health Innovation Conference
June 15, 2021
From
Silverback Therapeutics, Inc.
Via
Business Wire
Silverback Therapeutics to Participate in the Goldman Sachs 42nd Annual Global Healthcare Conference
June 01, 2021
From
Silverback Therapeutics, Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For May 27, 2021
May 27, 2021
Upgrades Craig-Hallum upgraded the previous rating for NVIDIA Corp (NASDAQ:NVDA) from Hold to Buy. In the first quarter, NVIDIA showed an EPS of $3.66, compared to $1.80...
Via
Benzinga
The Daily Biotech Pulse: CorMedix Slumps On Delay In Resubmission of DefenCath NDA, Apellis Awaits FDA Decision, Vera Therapeutics Debuts
May 14, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 13) Alexion Pharmaceuticals, Inc...
Via
Benzinga
Exposures
Product Safety
Silverback Therapeutics Reports First Quarter 2021 Financial Results
May 13, 2021
From
Silverback Therapeutics, Inc.
Via
Business Wire
Silverback Therapeutics to Present SBT6290 Preclinical Data at the AACR 2021 Annual Conference
April 08, 2021
From
Silverback Therapeutics, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.